UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Engineered bacterial communication prevents Vibrio cholerae virulence in an infant mouse model

Proceedings of the National Academy of Sciences - PNAS, 2010-06, Vol.107 (25), p.11260-11264

2010

Volltextzugriff (PDF)

Engineered probiotic Escherichia coli can eliminate and prevent Pseudomonas aeruginosa gut infection in animal models

Nature communications, 2017-04, Vol.8 (1), p.15028-15028, Article 15028

2017

Volltextzugriff (PDF)

Engineering probiotics to inhibit Clostridioides difficile infection by dynamic regulation of intestinal metabolism

Nature communications, 2022-07, Vol.13 (1), p.3834-3834, Article 3834

2022

Volltextzugriff (PDF)

Synthetic small intestinal scaffolds for improved studies of intestinal differentiation

Biotechnology and bioengineering, 2014-06, Vol.111 (6), p.1222-1232

2014

Volltextzugriff (PDF)

3‑D Intestinal Scaffolds for Evaluating the Therapeutic Potential of Probiotics

Molecular pharmaceutics, 2014-07, Vol.11 (7), p.2030-2039

2014

Volltextzugriff (PDF)

Ancylostoma ceylanicum infective third-stage larvae are activated by co-culture with HT-29-MTX intestinal epithelial cells

Parasites & vectors, 2017-12, Vol.10 (1), p.606-606, Article 606

2017

Volltextzugriff (PDF)

Secretion of Insulinotropic Proteins by Commensal Bacteria: Rewiring the Gut To Treat Diabetes

Applied and Environmental Microbiology, 2008-12, Vol.74 (23), p.7437-7438

2008

Volltextzugriff (PDF)

Engineered commensal bacteria reprogram intestinal cells into glucose-responsive insulin-secreting cells for the treatment of diabetes

Diabetes (New York, N.Y.), 2015-05, Vol.64 (5), p.1794-1803

2015

Volltextzugriff (PDF)

Engineering Escherichia coli for diagnosis and management of hyperuricemia

Frontiers in bioengineering and biotechnology, 2023-05, Vol.11, p.1191162-1191162

2023

Volltextzugriff (PDF)

luxS-Dependent Gene Regulation in Escherichia coli K-12 Revealed by Genomic Expression Profiling

Journal of Bacteriology, 2005-12, Vol.187 (24), p.8350-8360

2005

Volltextzugriff (PDF)

In vitro 3D human small intestinal villous model for drug permeability determination

Biotechnology and bioengineering, 2012-09, Vol.109 (9), p.2173-2178

2012

Volltextzugriff (PDF)

Microscale 3-D hydrogel scaffold for biomimetic gastrointestinal (GI) tract model

Lab on a chip, 2011-02, Vol.11 (3), p.389-392

2011

Volltextzugriff (PDF)

Microscale 3-D hydrogel scaffold for biomimetic gastrointestinal (GI) tract model

Lab on a chip, 2011, Vol.11 (3), p.389-392

2011

Volltextzugriff (PDF)

GM1-functionalized liposomes in a microtiter plate assay for cholera toxin in Vibrio cholerae culture samples

Analytical biochemistry, 2007-09, Vol.368 (1), p.39-48

2007

Volltextzugriff (PDF)

On chip porous polymer membranes for integration of gastrointestinal tract epithelium with microfluidic ‘body-on-a-chip’ devices

Biomedical microdevices, 2012-10, Vol.14 (5), p.895-906

2012

Volltextzugriff (PDF)

Electrochemical reverse engineering: A systems-level tool to probe the redox-based molecular communication of biology

Free radical biology & medicine, 2017-04, Vol.105, p.110-131

2017

Volltextzugriff (PDF)

LuxS Coexpression Enhances Yields of Recombinant Proteins in Escherichia coli in Part through Posttranscriptional Control of GroEL

Applied and Environmental Microbiology, 2011-03, Vol.77 (6), p.2141-2152

2011

Volltextzugriff (PDF)

Three dimensional human small intestine models for ADME-Tox studies

Drug discovery today, 2014-10, Vol.19 (10), p.1587-1594

2014

Volltextzugriff (PDF)

Transcytosis of IgA Attenuates Salmonella Invasion in Human Enteroids and Intestinal Organoids

Infection and immunity, 2022-06, Vol.90 (6), p.e0004122-e0004122

2022

Volltextzugriff (PDF)

Microscale Bioreactors for in situ characterization of GI epithelial cell physiology

Scientific reports, 2017-10, Vol.7 (1), p.12515-10, Article 12515

2017

Volltextzugriff (PDF)

Tissue engineering for the treatment of short bowel syndrome in children

Pediatric research, 2018-01, Vol.83 (1-2), p.249-257

2018

Volltextzugriff (PDF)

Targeting the pregnane X receptor using microbial metabolite mimicry

EMBO molecular medicine, 2020-04, Vol.12 (4), p.e11621-n/a

2020

Volltextzugriff (PDF)

Intestinal stem cell growth and differentiation on a tubular scaffold with evaluation in small and large animals

Regenerative medicine, 2016-01, Vol.11 (1), p.45-61

2016

Volltextzugriff (PDF)

An Engineered Probiotic Produces a Type III Interferon IFNL1 and Reduces Inflammations in in vitro Inflammatory Bowel Disease Models

ACS biomaterials science & engineering, 2023-09, Vol.9 (9), p.5123-5135

2023

Volltextzugriff (PDF)

Development of a synthetic receptor protein for sensing inflammatory mediators interferon-γ and tumor necrosis factor-α

Biotechnology and bioengineering, 2016-03, Vol.113 (3), p.492-500

2016

Volltextzugriff (PDF)

1 – 25 von 295

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(256)
Mit Volltextzugriff
(264)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(197)
Life Sciences & Biomedicine
(171)
Humans
(167)
Female
(110)
Male
(107)
Social Sciences
(89)
Biological And Medical Sciences
(87)
Child
(86)
Psychology
(86)
Medical Sciences
(71)
Psychiatry
(70)
Adolescent
(65)
Psychology, Developmental
(61)
Psychology. Psychoanalysis. Psychiatry
(56)
Pediatrics
(50)
Psychopathology. Psychiatry
(50)
Combined Modality Therapy
(44)
Treatment Outcome
(43)
Animals
(40)
Children
(40)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Engineered bacterial communication prevents Vibrio cholerae virulence in an infant mouse model

Engineered probiotic Escherichia coli can eliminate and prevent Pseudomonas aeruginosa gut infection in animal models

Engineering probiotics to inhibit Clostridioides difficile infection by dynamic regulation of intestinal metabolism

Synthetic small intestinal scaffolds for improved studies of intestinal differentiation

3‑D Intestinal Scaffolds for Evaluating the Therapeutic Potential of Probiotics

Ancylostoma ceylanicum infective third-stage larvae are activated by co-culture with HT-29-MTX intestinal epithelial cells

Secretion of Insulinotropic Proteins by Commensal Bacteria: Rewiring the Gut To Treat Diabetes

Engineered commensal bacteria reprogram intestinal cells into glucose-responsive insulin-secreting cells for the treatment of diabetes

Engineering Escherichia coli for diagnosis and management of hyperuricemia

luxS-Dependent Gene Regulation in Escherichia coli K-12 Revealed by Genomic Expression Profiling

In vitro 3D human small intestinal villous model for drug permeability determination

Microscale 3-D hydrogel scaffold for biomimetic gastrointestinal (GI) tract model

Microscale 3-D hydrogel scaffold for biomimetic gastrointestinal (GI) tract model

GM1-functionalized liposomes in a microtiter plate assay for cholera toxin in Vibrio cholerae culture samples

On chip porous polymer membranes for integration of gastrointestinal tract epithelium with microfluidic ‘body-on-a-chip’ devices

Electrochemical reverse engineering: A systems-level tool to probe the redox-based molecular communication of biology

LuxS Coexpression Enhances Yields of Recombinant Proteins in Escherichia coli in Part through Posttranscriptional Control of GroEL

Three dimensional human small intestine models for ADME-Tox studies

Transcytosis of IgA Attenuates Salmonella Invasion in Human Enteroids and Intestinal Organoids

Microscale Bioreactors for in situ characterization of GI epithelial cell physiology

Tissue engineering for the treatment of short bowel syndrome in children

Targeting the pregnane X receptor using microbial metabolite mimicry

Intestinal stem cell growth and differentiation on a tubular scaffold with evaluation in small and large animals

An Engineered Probiotic Produces a Type III Interferon IFNL1 and Reduces Inflammations in in vitro Inflammatory Bowel Disease Models

Development of a synthetic receptor protein for sensing inflammatory mediators interferon-γ and tumor necrosis factor-α

Suchergebnisse filtern